BR112018002395A2 - “variantes de promotor, ácido nucleico do promotor operacionalmente ligado a uma sequência de sinal e uma sequência que codifica uma proteína,construção de expressão, célula hospedeira quecompreende tal construção de expressão, e métodode produção de uma poi - Google Patents

“variantes de promotor, ácido nucleico do promotor operacionalmente ligado a uma sequência de sinal e uma sequência que codifica uma proteína,construção de expressão, célula hospedeira quecompreende tal construção de expressão, e métodode produção de uma poi

Info

Publication number
BR112018002395A2
BR112018002395A2 BR112018002395A BR112018002395A BR112018002395A2 BR 112018002395 A2 BR112018002395 A2 BR 112018002395A2 BR 112018002395 A BR112018002395 A BR 112018002395A BR 112018002395 A BR112018002395 A BR 112018002395A BR 112018002395 A2 BR112018002395 A2 BR 112018002395A2
Authority
BR
Brazil
Prior art keywords
promoter
seq
expression construct
sequence
region
Prior art date
Application number
BR112018002395A
Other languages
English (en)
Portuguese (pt)
Inventor
Brigitte Gasser
Diethard Mattanovich
Roland Prielhofer
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of BR112018002395A2 publication Critical patent/BR112018002395A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/001Vector systems having a special element relevant for transcription controllable enhancer/promoter combination

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112018002395A 2015-08-05 2016-08-05 “variantes de promotor, ácido nucleico do promotor operacionalmente ligado a uma sequência de sinal e uma sequência que codifica uma proteína,construção de expressão, célula hospedeira quecompreende tal construção de expressão, e métodode produção de uma poi BR112018002395A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2015068024 2015-08-05
EP16163932 2016-04-05
PCT/EP2016/068784 WO2017021541A1 (en) 2015-08-05 2016-08-05 Promoter variants

Publications (1)

Publication Number Publication Date
BR112018002395A2 true BR112018002395A2 (pt) 2018-09-18

Family

ID=56684642

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018002395A BR112018002395A2 (pt) 2015-08-05 2016-08-05 “variantes de promotor, ácido nucleico do promotor operacionalmente ligado a uma sequência de sinal e uma sequência que codifica uma proteína,construção de expressão, célula hospedeira quecompreende tal construção de expressão, e métodode produção de uma poi

Country Status (13)

Country Link
US (2) US10752907B2 (https=)
EP (1) EP3332005B1 (https=)
JP (1) JP6833812B2 (https=)
KR (1) KR102253479B1 (https=)
CN (1) CN108350447B (https=)
AU (1) AU2016303026B2 (https=)
BR (1) BR112018002395A2 (https=)
CA (1) CA2992170C (https=)
DK (1) DK3332005T3 (https=)
ES (1) ES2902044T3 (https=)
IL (1) IL257000B (https=)
TW (1) TW201718859A (https=)
WO (1) WO2017021541A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI560272B (en) 2011-10-07 2016-12-01 Lonza Ag Regulatable promoter
JP7717459B2 (ja) 2018-02-12 2025-08-04 ロンザ リミテッド 目的タンパク質を産生するための宿主細胞
EP3536784A1 (en) 2018-03-05 2019-09-11 ACIB GmbH Host cell engineered for improved metabolite production
EP3802832A1 (en) * 2018-06-07 2021-04-14 Basf Se Promoter for yeast
EP3824083A4 (en) * 2018-09-24 2022-01-05 Orta Dogu Teknik Universitesi Design of alcohol dehydrogenase 2 (adh2) promoter variants by promoter engineering
JP2022502018A (ja) * 2018-09-24 2022-01-11 オルタ ドグ テクニク ユニヴェルシテシ 改変されたaox1プロモータバリアント
DK3874047T4 (da) * 2019-01-11 2025-02-03 Lonza Ag Karbonkilde-reguleret proteinproduktion i en rekombinant værtscelle
RS64248B1 (sr) * 2019-01-29 2023-06-30 Clariant Produkte Deutschland Gmbh Himerni promotor za upotrebu u metaboličkom inženjeringu
AU2020252241B2 (en) 2019-04-01 2024-03-21 Universität Für Bodenkultur Wien Mut- methylotrophic yeast
WO2020200414A1 (en) 2019-04-01 2020-10-08 Lonza Ltd Protein production in mut-methylotrophic yeast
WO2020200415A1 (en) 2019-04-01 2020-10-08 Lonza Ltd Mut- methylotrophic yeast
US11618900B2 (en) * 2019-11-01 2023-04-04 The Johns Hopkins University Modulating SYNGAP
EP4127185B1 (en) 2020-04-01 2025-06-04 Lonza Ltd. Helper factors for expressing proteins in yeast
CA3174666A1 (en) * 2020-04-09 2021-10-14 Robert Schlegl Improved methods of producing a lipidated protein
CA3193155A1 (en) 2020-09-30 2022-04-07 Lonza Ltd Host cells overexpressing translational factors
IL304910A (en) 2021-02-12 2023-10-01 Boehringer Ingelheim Rcv Gmbh Signal peptides for increased protein secretion
CN114657190B (zh) * 2022-04-06 2023-08-29 暨南大学 Msn2p作为负调控因子在提高宿主细胞中蛋白表达中的应用
CN114908092B (zh) * 2022-05-12 2023-07-18 华南理工大学 一种长效、高强度的杂合启动子及其重组菌株和应用
EP4353825A1 (en) * 2022-10-10 2024-04-17 bisy GmbH Modified promoter sequences
WO2024133538A1 (en) 2022-12-20 2024-06-27 Lonza Ltd Host cells with pat1 knockout for increased specific protein productivity
EP4726051A1 (en) * 2023-06-06 2026-04-15 FUJIFILM Corporation Recombinant yeast, method for producing target protein, and kit and method for producing recombinant yeast
CN121358867A (zh) * 2023-06-15 2026-01-16 丹斯塔发酵股份公司 C2碳源响应性启动子
WO2025247966A1 (en) 2024-05-29 2025-12-04 Mybios Gmbh Process for protein production in methylotrophic yeast host cell.
WO2026027251A1 (en) 2024-08-01 2026-02-05 Boehringer Ingelheim Rcv Gmbh & Co Kg Signal peptides for increased protein secretion
BE1032887B1 (nl) * 2024-08-26 2026-04-14 Anheuser Busch Inbev Sa Geoptimaliseerd promotorontwerp voor industriëe toepassing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT501955B1 (de) 2005-02-23 2007-08-15 Univ Graz Tech Mutierte aox1-promotoren
US8105811B2 (en) 2008-06-13 2012-01-31 Wisconsin Alumni Research Foundation Sugar transport sequences, yeast strains having improved sugar uptake, and methods of use
EP2494053A4 (en) * 2009-10-30 2013-10-30 Merck Sharp & Dohme PROCESS FOR PRODUCING RECOMBINANT PROTEINS WITH INCREASED SECRETION EFFICIENCY
TWI560272B (en) * 2011-10-07 2016-12-01 Lonza Ag Regulatable promoter
AU2013341049B2 (en) 2012-10-29 2017-07-20 Lonza Ltd Expression sequences

Also Published As

Publication number Publication date
WO2017021541A1 (en) 2017-02-09
DK3332005T3 (da) 2022-01-03
JP6833812B2 (ja) 2021-02-24
CA2992170C (en) 2022-08-16
HK1251256A1 (zh) 2019-01-25
EP3332005A1 (en) 2018-06-13
CA2992170A1 (en) 2017-02-09
JP2018522565A (ja) 2018-08-16
US12522837B2 (en) 2026-01-13
CN108350447B (zh) 2021-08-31
KR20180037237A (ko) 2018-04-11
US20200347391A1 (en) 2020-11-05
AU2016303026B2 (en) 2020-10-22
TW201718859A (zh) 2017-06-01
IL257000A (en) 2018-03-29
CN108350447A (zh) 2018-07-31
EP3332005B1 (en) 2021-09-22
AU2016303026A1 (en) 2018-02-15
US10752907B2 (en) 2020-08-25
KR102253479B1 (ko) 2021-05-21
US20180223293A1 (en) 2018-08-09
ES2902044T3 (es) 2022-03-24
IL257000B (en) 2022-06-01

Similar Documents

Publication Publication Date Title
BR112018002395A2 (pt) “variantes de promotor, ácido nucleico do promotor operacionalmente ligado a uma sequência de sinal e uma sequência que codifica uma proteína,construção de expressão, célula hospedeira quecompreende tal construção de expressão, e métodode produção de uma poi
BR112018011059A2 (pt) synp161, um promotor para a expressão específica de genes em fotoreceptores de haste
CY1122800T1 (el) Συνθεσεις του παραγοντα viii και μεθοδοι δημιουργιας και χρησης αυτων
BR112012012374A2 (pt) semente de planta com maior teor de óleo, planta, método para aumentar ainda mais o teor de óleo em uma semente de planta de alto teor de óleo, método par avaliar o teor de óleo aumentado em uma semente de planta, polinucleotídeo isolado polipeptídeo isolado
BR112021021912A2 (pt) Nova nuclease omni-50 crispr
CU24606B1 (es) Moléculas de anticuerpo que se unen a cd73
JP2016034981A5 (https=)
BR112019008488A2 (pt) synp198, promotor para a expressão específica de genes em células ganglionares retinianas de direção seletiva
CR20150196A (es) Moléculas de unión il-17a novedosas y usos médicos de las mismas
WO2015027259A3 (de) Polypeptid zur hydrolytischen spaltung von zearalenon und/oder zearalenon-derivaten, isoliertes polynukleotid davon sowie einen zusatzstoff enthaltendes polypeptid, verwendung desselben sowie verfahren
MX394221B (es) Metodos de reduccion de olor.
BR112015022507A2 (pt) ácidos ribonucleicos com nucleotídeos 4'-tio-modificados, composição compreendendo o mesmo e usos relacionados
SG10201906859PA (en) Novel proteins specific for angiogenesis
BR112015001390A2 (pt) vacina de proteína de fusão multimérica e imunoterápicos
CU20170112A7 (es) Variantes de polipeptidos que dividen toxinas de fusarium, aditivo que contiene estas variantes y su uso, así como procedimientos para la división de toxinas de fusarium
CO2017012454A2 (es) Secuencias de uricasa adecuadas para el tratamiento de hiperuricemia
EA201491643A1 (ru) Идентификация мутаций канал-опсина-2 (chop2) и способы применения
MX2023007319A (es) Vacunas de acido nucleico.
BR112015008815A2 (pt) variantes do receptor iib de fc gama
BR112017014580A8 (pt) Método para obter um isolado peptídico a partir de uma biomassa de microalgas enriquecidas com proteína
NZ752941A (en) Frataxin expression constructs
BR112013025819A2 (pt) promotor específico para semente em algodão
MX2021013879A (es) Variantes de lipasa y polinucleotidos que las codifican.
BR112016022508A2 (pt) anticorpos contra hpa-1a
BR112018003580A2 (pt) molécula de ácido nucléico, método para apresentar um polipeptídeo alvo, proteína recombinante, partícula do tipo viral, composição farmacêutica, polipeptídeo, vetor, célula hospedeira e método para preparar a proteína recombinante

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2682 DE 31-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.